Due for re-check: the scheduled review date of 2026-09-13 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
0009-0870-26 · Clindamycin Phosphate Injection · Pfizer Inc.
What is the package ndc for 0009-0870-26 · Clindamycin Phosphate Injection · Pfizer Inc.?
For 0009-0870-26 · Clindamycin Phosphate Injection · Pfizer Inc., package ndc is 0009-0870-26; generic name is Clindamycin Phosphate Injection; manufacturer is Pfizer Inc; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01; source re-checked 2026-09-10.
"initial_posting_date": "03/21/2023", "package_ndc": "0009-0870-26", "generic_name": "Clindamycin Phosphate Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d", "contact_info": "800-533-4535", "availability": "Unavailable", "related_info": "Next Delivery and Estimated Recovery: December 2028"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 0009-0870-26 verified
- Generic name
- Clindamycin Phosphate Injection verified
- Manufacturer
- Pfizer Inc. verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Next Delivery and Estimated Recovery: December 2028 verified
- Initial posting date
- 03/21/2023 verified
- Last update date
- 08/24/2026 verified
- Days in shortage
- 1260 our reading
- Reason for shortage
- Demand increase for the drug verified
- Dosage form
- Injection verified
- Therapeutic category
- Anti-Infective verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/24/2026", "therapeutic_category": [ "Anti-Infective" ], "dosage_form": "Injection", "presentation": "Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)", "company_name": "Pfizer Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000